[
    [
        {
            "time": "2019-01-03",
            "original_text": "Biotech ETFs Hit New Highs on Deal Activities",
            "features": {
                "keywords": [
                    "Biotech",
                    "ETFs",
                    "New Highs",
                    "Deal Activities"
                ],
                "sentiment_score": 0.75,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "biotech"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Biotech ETFs Hit New Highs on Deal Activities",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 5,
                "Market_Scope": 9,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "2019-04-15",
            "original_text": "Merck Stock Is On An Upswing In 2019 — Should You Buy This Pharma Stock?",
            "features": {
                "keywords": [
                    "Merck",
                    "Upswing",
                    "Pharma",
                    "Stock"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Merck Stock Is On An Upswing In 2019 — Should You Buy This Pharma Stock?",
                "Correlation": 10,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 5,
                "Headline_Structure": 9,
                "Source_Recency": 6
            }
        },
        {
            "time": "2019-12-01",
            "original_text": "Drug manufacturers have spent a record $342 billion on M&A in 2019",
            "features": {
                "keywords": [
                    "Drug manufacturers",
                    "M&A",
                    "record",
                    "$342 billion"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "Drug manufacturers have spent a record $342 billion on M&A in 2019",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 6,
                "Market_Scope": 10,
                "Time_Proximity": 5,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        }
    ]
]